SAN DIEGO--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, announced today that management will hold a conference call to discuss 2010 second quarter financial results and ongoing corporate activities, on Friday, August 13, 2010 at 12:00 p.m. ET. The Company will file its Form 10-Q by the end of business on Thursday, August 12, 2010.
